Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Da-Lin He"'
Autor:
Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhang-Qun Ye, Hiroyoshi Suzuki, Taek Won Kang, Da-Lin He, Jae Young Joung, Sabine D Brookman-May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Ding-Wei Ye, Kim N Chi, Hirotsugu Uemura
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 6, Pp 653-661 (2023)
The final analysis of the phase 3 Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) trial showed improvement in overall survival (OS) and other efficacy endpoints with apalutamide plus androgen deprivation therapy (ADT) versu
Externí odkaz:
https://doaj.org/article/c78d4747b1574342b443336c6734afee
Autor:
Ying-Hui Jin, Xian-Tao Zeng, Tong-Zu Liu, Zhi-Ming Bai, Zhong-Ling Dou, De-Gang Ding, Zhi-Lu Fan, Ping Han, Yi-Ran Huang, Xing Huang, Ming Li, Xiao-Dong Li, Yi-Ning Li, Xu-Hui Li, Chao-Zhao Liang, Jiu-Min Liu, Hong-Shun Ma, Juan Qi, Jia-Qi Shi, Jian Wang, De-Lin Wang, Zhi-Ping Wang, Yun-Yun Wang, Yong-Bo Wang, Qiang Wei, Hai-Bo Xia, Jin-Chun Xing, Si-Yu Yan, Xue-Pei Zhang, Guo-You Zheng, Nian-Zeng Xing, Da-Lin He, Xing-Huan Wang, the Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA)
Publikováno v:
Military Medical Research, Vol 9, Iss 1, Pp 1-21 (2022)
Abstract Non-muscle invasive bladder cancer (NMIBC) is a major type of bladder cancer with a high incidence worldwide, resulting in a great disease burden. Treatment and surveillance are the most important part of NIMBC management. In 2018, we issued
Externí odkaz:
https://doaj.org/article/ac91be5a979c41c69e7342eb743921a0
Autor:
Xian-Tao Zeng, Ying-Hui Jin, Tong-Zu Liu, Fang-Ming Chen, De-Gang Ding, Meng Fu, Xin-Quan Gu, Bang-Min Han, Xing Huang, Zhi Hou, Wan-Li Hu, Xin-Li Kang, Gong-Hui Li, Jian-Xing Li, Pei-Jun Li, Chao-Zhao Liang, Xiu-Heng Liu, Zhi-Yu Liu, Chun-Xiao Liu, Jiu-Min Liu, Guang-Heng Luo, Yi Luo, Wei-Jun Qin, Jian-Hong Qiu, Jian-Xin Qiu, Xue-Jun Shang, Ben-Kang Shi, Fa Sun, Guo-Xiang Tian, Ye Tian, Feng Wang, Yin-Huai Wang, Yu-Jie Wang, Zhi-Ping Wang, Zhong Wang, Qiang Wei, Min-Hui Xiao, Wan-Hai Xu, Fa-Xian Yi, Chao-Yang Zhu, Qian-Yuan Zhuang, Li-Qun Zhou, Xiao-Feng Zou, Nian-Zeng Xing, Da-Lin He, Xing-Huan Wang, the Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange and Promotive Association for Medical and Health Care (CPAM-UHPA)
Publikováno v:
Military Medical Research, Vol 9, Iss 1, Pp 1-19 (2022)
Abstract Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resectio
Externí odkaz:
https://doaj.org/article/a06a8c05b012497ca1723331a9da92d7
Autor:
Byung Ha Chung, Jian Huang, Zhang-Qun Ye, Da-Lin He, Hirotsugu Uemura, Gaku Arai, Choung Soo Kim, Yuan-Yuan Zhang, Yusoke Koroki, SuYeon Jeong, Suneel Mundle, Spyros Triantos, Sharon McCarthy, Kim N Chi, Ding-Wei Ye
Publikováno v:
Asian Journal of Andrology, Vol 24, Iss 2, Pp 161-166 (2022)
Ethnicity might be associated with treatment outcomes in advanced prostate cancer. This study aimed to evaluate the efficacy and safety of androgen deprivation therapy (ADT) combined with apalutamide in East Asians with metastatic castration-sensitiv
Externí odkaz:
https://doaj.org/article/9018fc34a228416d9d780426e11c2984
Autor:
Hao Zi, Shao-Hua He, Xie-Yuan Leng, Xiao-Feng Xu, Qiao Huang, Hong Weng, Cong Zhu, Lu-Yao Li, Jia-Min Gu, Xu-Hui Li, Dao-Jing Ming, Xiao-Dong Li, Shuai Yuan, Xing-Huan Wang, Da-Lin He, Xian-Tao Zeng
Publikováno v:
Military Medical Research, Vol 8, Iss 1, Pp 1-15 (2021)
Abstract Background The burden of kidney, bladder, and prostate cancers has changed in recent decades. This study aims to investigate the global and regional burden of, and attributable risk factors for genitourinary cancers during the past 30 years.
Externí odkaz:
https://doaj.org/article/bdecef20c81b4a71a56062e665064f54
Publikováno v:
American Journal of Men's Health, Vol 15 (2021)
The objective of this study is to provide comprehensive and up-to-date estimates on the disease burden of BPH in 204 countries and territories between 1990 and 2019. Data about incidence, year lived with disability (YLD), and their age-standardized r
Externí odkaz:
https://doaj.org/article/ded2c1e77b064a2db0826c659079faa3
Publikováno v:
Asian Journal of Andrology, Vol 20, Iss 2, Pp 173-177 (2018)
Docetaxel-based chemotherapy remains the first-line treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) in China; however, the prognostic factors associated with effects in these patients are still controversial. In th
Externí odkaz:
https://doaj.org/article/172583a3c142412dafd61169d6d17961
Publikováno v:
Asian Journal of Andrology, Vol 20, Iss 2, Pp 200-204 (2018)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for anticancer therapy. The identification of small molecules that can establish the sensitivity of prostate cancer (PCa) cells to TRAIL-induced apoptosis is crucial
Externí odkaz:
https://doaj.org/article/dcde15e8aa6e469ba5655ccf3ec47a6a
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Background and Objective: Studies suggests that matrix metalloproteinase (MMP)-2-1306 C/T and MMP-1-1607 1G/2G polymorphisms affect the risk of prostate cancer. However, the conclusions remain controversial and no pooled evidence of this topic has be
Externí odkaz:
https://doaj.org/article/49423c5e5d06455da45587dd91ac289f
Autor:
Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Publikováno v:
Asian Journal of Andrology, Vol 17, Iss 6, Pp 1017-1021 (2015)
Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0-10.0 ng ml−1 , however, it remains controversial whether %fPSA is effective in PSA range of 10.1-2
Externí odkaz:
https://doaj.org/article/96a61c0ae72e4bc2bc900734591d98fe